Immunic Statistics

Total Valuation

Immunic has a market cap or net worth of $140.25 million. The enterprise value is $116.73 million.

Market Cap	140.25M
Enterprise Value	116.73M

Important Dates

The next estimated earnings date is Thursday, May 14, 2026, after market close.

Earnings Date	May 14, 2026
Ex-Dividend Date	n/a

Share Statistics

Immunic has 13.05 million shares outstanding. The number of shares has increased by 55.42% in one year.

Current Share Class	13.05M
Shares Outstanding	13.05M
Shares Change (YoY)	+55.42%
Shares Change (QoQ)	+0.22%
Owned by Insiders (%)	1.33%
Owned by Institutions (%)	42.97%
Float	10.71M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.75

Current Ratio	0.75
Quick Ratio	0.64
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -1,653.15% and return on invested capital (ROIC) is -967.50%.

Return on Equity (ROE)	-1,653.15%
Return on Assets (ROA)	-198.76%
Return on Invested Capital (ROIC)	-967.50%
Return on Capital Employed (ROCE)	1,572.16%
Weighted Average Cost of Capital (WACC)	11.74%
Revenue Per Employee	n/a
Profits Per Employee	-$1.06M
Employee Count	92
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -3.15% in the last 52 weeks. The beta is 1.37, so Immunic's price volatility has been higher than the market average.

Beta (5Y)	1.37
52-Week Price Change	-3.15%
50-Day Moving Average	11.00
200-Day Moving Average	8.61
Relative Strength Index (RSI)	50.96
Average Volume (20 Days)	303,660

Short Selling Information

The latest short interest is 8.33 million, so 63.83% of the outstanding shares have been sold short.

Short Interest	8.33M
Short Previous Month	8.95M
Short % of Shares Out	63.83%
Short % of Float	77.74%
Short Ratio (days to cover)	4.05

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-103.23M
Pretax Income	-97.17M
Net Income	-97.17M
EBITDA	-103.06M
EBIT	-103.23M
Earnings Per Share (EPS)	-$6.24

Full Income Statement

Balance Sheet

The company has $15.48 million in cash and $577,000 in debt, giving a net cash position of $14.91 million or $1.14 per share.

Cash & Cash Equivalents	15.48M
Total Debt	577,000
Net Cash	14.91M
Net Cash Per Share	$1.14
Equity (Book Value)	-6.67M
Book Value Per Share	-0.55
Working Capital	-7.75M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$85.81 million and capital expenditures -$161,000, giving a free cash flow of -$85.97 million.

Operating Cash Flow	-85.81M
Capital Expenditures	-161,000
Depreciation & Amortization	168,000
Net Borrowing	n/a
Free Cash Flow	-85.97M
FCF Per Share	-$6.59

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Immunic does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-55.42%
Shareholder Yield	-55.42%
Earnings Yield	-73.82%
FCF Yield	-65.31%

Analyst Forecast

The average price target for Immunic is $45.00, which is 318.61% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$45.00
Price Target Difference	318.61%
Analyst Consensus	Strong Buy
Analyst Count	6
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on April 27, 2026. It was a reverse split with a ratio of 1:10.

Last Split Date	Apr 27, 2026
Split Type	Reverse
Split Ratio	1:10

Scores

Altman Z-Score	n/a
Piotroski F-Score	1